Ashwagandha is not FDA approved. It is classified as a dietary supplement in the United States, which means it has never gone through the FDA’s drug approval process and is not evaluated for safety or effectiveness before it hits store shelves. This distinction matters because it shapes what manufacturers can claim, what quality you can expect, and how much of the safety burden falls on you as a consumer.
Why Supplements Don’t Need FDA Approval
The FDA regulates dietary supplements under a completely different framework than prescription or over-the-counter drugs. Under the Dietary Supplement Health and Education Act of 1994 (DSHEA), supplement manufacturers are responsible for evaluating the safety and labeling of their own products before selling them. The FDA does not review or verify that evaluation. Its authority kicks in only after a product reaches the market, and only if it turns out to be adulterated or mislabeled.
In practical terms, this means no one at the FDA has reviewed clinical trial data on ashwagandha and determined it works for any health condition. A prescription drug has to prove it’s both safe and effective in rigorous trials before the FDA grants approval. Ashwagandha has never been held to that standard, and no supplement has.
What About GRAS Status?
You may have seen certain ashwagandha products labeled “GRAS,” which stands for Generally Recognized as Safe. One popular branded extract, KSM-66, claims to be “self-affirmed GRAS” for use in some foods after an independent panel of experts reviewed its safety data. That sounds official, but it’s an important distinction: the FDA itself has not recognized ashwagandha as GRAS. Self-affirmed GRAS means the company hired outside experts to review the ingredient and those experts concluded it was safe. The FDA was not involved in that determination.
What Ashwagandha Labels Can Legally Say
Because ashwagandha isn’t an approved drug, manufacturers are legally prohibited from claiming it can diagnose, treat, cure, or prevent any disease. What they can make are “structure/function claims,” which describe how an ingredient affects normal body functions. Examples include phrases like “supports a healthy stress response” or “promotes relaxation.” These claims don’t require pre-approval from the FDA, though manufacturers must notify the agency within 30 days of using them and must have some substantiation that the claim isn’t misleading.
Every ashwagandha supplement carrying one of these claims is required to include a disclaimer on the label stating that the FDA has not evaluated the claim and that the product is not intended to treat any disease. If you’ve seen that small-print disclaimer on a bottle, now you know what it means.
What Research Actually Shows
The lack of FDA approval doesn’t mean ashwagandha is unstudied. Clinical trials have tested it across a range of doses, typically 300 to 600 mg per day of root extract standardized to about 5% withanolides (the plant’s active compounds). An international task force created by the World Federation of Societies of Biological Psychiatry and the Canadian Network for Mood and Anxiety Treatments has provisionally recommended this dose range for generalized anxiety, though “provisionally” signals that the evidence is still emerging rather than settled.
Several randomized, placebo-controlled trials have found that ashwagandha significantly reduced self-reported stress and anxiety, improved sleep quality, and lowered cortisol, the body’s primary stress hormone. Benefits appeared to be more consistent at doses of 500 to 600 mg per day compared to lower doses. These are real findings from controlled studies, but they are generally small and short-term, which is part of why ashwagandha remains a supplement rather than an approved treatment.
Safety Concerns Worth Knowing
Ashwagandha is widely considered safe for most people in the short term, and clinical trials have not reported serious adverse events. But post-market reports tell a more cautious story. Cases of clinically apparent liver injury have been linked to commercial ashwagandha products, typically showing up 2 to 12 weeks after someone starts taking it. Symptoms include jaundice (yellowing of the skin or eyes) and itching. The National Institutes of Health’s LiverTox database rates ashwagandha as a “likely cause of clinically apparent liver injury,” though it notes these cases are rare.
Most reported cases have been mild to moderate and resolved on their own after stopping the supplement. However, rare fatal cases involving acute liver failure have been described, particularly in people who already had liver disease or cirrhosis. Because commercial herbal products are sometimes mixtures of multiple ingredients and can be mislabeled, it’s not always clear whether the liver injury came from ashwagandha itself or from a contaminant in the product. This uncertainty is one of the inherent risks of an unregulated supplement market.
Some Countries Have Restricted It
While ashwagandha remains freely available in the U.S., not every country treats it the same way. Denmark banned ashwagandha supplements entirely, with its food safety authority citing concerns about negative effects on sex hormones and reproduction in both men and women, as well as potential impacts on metabolism, the immune system, and the central nervous system. Germany has raised similar concerns based on the same underlying research, though it has not imposed an outright ban. These regulatory decisions reflect a more precautionary approach than the U.S. system, where the burden of proof falls on the FDA to show a product is harmful rather than on the manufacturer to prove it’s safe.
What This Means for You
The fact that ashwagandha isn’t FDA approved doesn’t automatically mean it’s dangerous or useless. It means no federal agency has independently verified its safety profile or confirmed it works for any specific condition. The quality of what’s inside the bottle varies by manufacturer, and no one is checking before it ships. If you choose to use ashwagandha, look for products that have been third-party tested by organizations like USP, NSF International, or ConsumerLab, which verify that the supplement contains what the label says and is free of common contaminants. That won’t replace FDA oversight, but it narrows the gap considerably.